img

Global Glucosylceramidase Industry Research Report, Growth Trends and Competitive Analysis 2024-2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Glucosylceramidase Industry Research Report, Growth Trends and Competitive Analysis 2024-2034

The global Glucosylceramidase market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2034 with a CAGR of % during the forecast period 2024-2034.
The United States market for Glucosylceramidase is estimated to increase from $ million in 2023 to reach $ million by 2034, at a CAGR of % during the forecast period of 2023 through 2034.
The China market for Glucosylceramidase is estimated to increase from $ million in 2023 to reach $ million by 2034, at a CAGR of % during the forecast period of 2023 through 2034.
The Europe market for Glucosylceramidase is estimated to increase from $ million in 2023 to reach $ million by 2034, at a CAGR of % during the forecast period of 2023 through 2034..
The global key manufacturers of Glucosylceramidase include Amicus Therapeutics, Inc., Bioorganic Research and Services S.A., greenovation Biotech GmbH, JCR Pharmaceuticals Co., Ltd., Pharming Group N.V., Protalix BioTherapeutics, Inc., Takeda and The International Biotechnology Center (IBC) Generium, etc. In 2024, the global top five players hold a share approximately % in sales volume, and in term of revenue of Glucosylceramidase, the top five companies hold a share nearly %.
In terms of sales (consumption) side, this report focuses on the sales of Glucosylceramidase by regions (Countries), company, by type and by type. from 2018 to 2023 and forecast to 2034.
The global Glucosylceramidase market is thoroughly, accurately, and comprehensively assessed in the report with a large focus on market dynamics, market competition, regional growth, segmental analysis, and key growth strategies. Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of sales analysis, the authors of the report have provided reliable estimations and calculations for global revenue and sales by type segment of the global Glucosylceramidase market. These figures have been provided in terms of both revenue and sales for the period 2018-2034. Additionally, the report provides accurate figures for sales by region in terms of revenue as well as volume for the same period.



By Company


Amicus Therapeutics, Inc.
Bioorganic Research and Services S.A.
greenovation Biotech GmbH
JCR Pharmaceuticals Co., Ltd.
Pharming Group N.V.
Protalix BioTherapeutics, Inc.
Takeda
The International Biotechnology Center (IBC) Generium
By Type
AVRRD-02
LTI-291
NCGC-607
Pcgin
Others
By Application
Genetic Disorders
Gaucher Disease
Parkinson's Disease
Others
Sales by Region
North America
U.S.
Canada
China
APAC (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Middle East, Africa, Latin America
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2Sales (consumption), revenue of Glucosylceramidase in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 3Detailed analysis of Glucosylceramidase manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6North America by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 7Europe by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 8China by company, by type and by application, sales, and revenue for each segment.
Chapter 9APAC (excluding China) by company, by type, by application and by region, sales, and revenue for each segment.
Chapter 10Middle East, Africa, and Latin America by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 11Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Glucosylceramidase sales, revenue, price, gross margin, and recent development, etc.
Chapter 12Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14The main points and conclusions of the report.

Table of Content

1 Report Overview
1.1 Glucosylceramidase Definition
1.2 Market by Type
1.2.1 Global Glucosylceramidase Market Size Growth Rate by Type, 2018 VS 2024 VS 2034
1.2.2 AVRRD-02
1.2.3 LTI-291
1.2.4 NCGC-607
1.2.5 Pcgin
1.2.6 Others
1.3 Market Segment by Application
1.3.1 Global Glucosylceramidase Market Size Growth Rate by Application, 2018 VS 2024 VS 2034
1.3.2 Genetic Disorders
1.3.3 Gaucher Disease
1.3.4 Parkinson's Disease
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Glucosylceramidase Sales
2.1 Global Glucosylceramidase Revenue Estimates and Forecasts 2018-2034
2.2 Global Glucosylceramidase Revenue by Region: 2018 VS 2024 VS 2034
2.3 Global Glucosylceramidase Revenue by Region
2.3.1 Global Glucosylceramidase Revenue by Region (2018-2023)
2.3.2 Global Glucosylceramidase Revenue by Region (2024-2034)
2.4 Global Glucosylceramidase Sales Quantity Estimates and Forecasts 2018-2034
2.5 Global Glucosylceramidase Sales Quantity by Region: 2018 VS 2024 VS 2034
2.6 Global Glucosylceramidase Sales Quantity by Region
2.6.1 Global Glucosylceramidase Sales Quantity by Region (2018-2023)
2.6.2 Global Glucosylceramidase Sales Quantity by Region (2024-2034)
2.7 North America
2.8 Europe
2.9 China
2.10 APAC (excluding China)
2.11 Middle East, Africa and Latin America
3 Competition by Manufacturers
3.1 Global Glucosylceramidase Sales Quantity by Manufacturers
3.1.1 Global Glucosylceramidase Sales Quantity by Manufacturers (2018-2023)
3.1.2 Global Glucosylceramidase Sales Quantity Share by Manufacturers (2018-2023)
3.1.3 Global Top 10 and Top 5 Companies by Glucosylceramidase Sales in 2024
3.2 Global Glucosylceramidase Revenue by Manufacturers
3.2.1 Global Glucosylceramidase Revenue by Manufacturers (2018-2023)
3.2.2 Global Glucosylceramidase Revenue Share by Manufacturers (2018-2023)
3.2.3 Global Top 10 and Top 5 Companies by Glucosylceramidase Revenue in 2024
3.3 Global Glucosylceramidase Sales Price by Manufacturers
3.4 Global Key Players of Glucosylceramidase, Industry Ranking, 2021 VS 2024
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Glucosylceramidase Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Glucosylceramidase, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Glucosylceramidase, Product Offered and Application
3.8 Global Key Manufacturers of Glucosylceramidase, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Estimates and Forecasts by Type
4.1 Global Glucosylceramidase Sales Quantity by Type
4.1.1 Global Glucosylceramidase Historical Sales Quantity by Type (2018-2023)
4.1.2 Global Glucosylceramidase Forecasted Sales Quantity by Type (2024-2034)
4.1.3 Global Glucosylceramidase Sales Quantity Market Share by Type (2018-2034)
4.2 Global Glucosylceramidase Revenue by Type
4.2.1 Global Glucosylceramidase Historical Revenue by Type (2018-2023)
4.2.2 Global Glucosylceramidase Forecasted Revenue by Type (2024-2034)
4.2.3 Global Glucosylceramidase Revenue Market Share by Type (2018-2034)
4.3 Global Glucosylceramidase Price by Type
4.3.1 Global Glucosylceramidase Price by Type (2018-2023)
4.3.2 Global Glucosylceramidase Price Forecast by Type (2024-2034)
5 Market Size by Application
5.1 Global Glucosylceramidase Sales Quantity by Application
5.1.1 Global Glucosylceramidase Historical Sales Quantity by Application (2018-2023)
5.1.2 Global Glucosylceramidase Forecasted Sales Quantity by Application (2024-2034)
5.1.3 Global Glucosylceramidase Sales Quantity Market Share by Application (2018-2034)
5.2 Global Glucosylceramidase Revenue by Application
5.2.1 Global Glucosylceramidase Historical Revenue by Application (2018-2023)
5.2.2 Global Glucosylceramidase Forecasted Revenue by Application (2024-2034)
5.2.3 Global Glucosylceramidase Revenue Market Share by Application (2018-2034)
5.3 Global Glucosylceramidase Price by Application
5.3.1 Global Glucosylceramidase Price by Application (2018-2023)
5.3.2 Global Glucosylceramidase Price Forecast by Application (2024-2034)
6 North America
6.1 North America Glucosylceramidase Sales by Company
6.1.1 North America Glucosylceramidase Revenue by Company (2018-2023)
6.1.2 North America Glucosylceramidase Sales Quantity by Company (2018-2023)
6.2 North America Glucosylceramidase Market Size by Type
6.2.1 North America Glucosylceramidase Sales Quantity by Type (2018-2034)
6.2.2 North America Glucosylceramidase Revenue by Type (2018-2034)
6.3 North America Glucosylceramidase Market Size by Application
6.3.1 North America Glucosylceramidase Sales Quantity by Application (2018-2034)
6.3.2 North America Glucosylceramidase Revenue by Application (2018-2034)
6.4 North America Glucosylceramidase Market Size by Country
6.4.1 North America Glucosylceramidase Revenue by Country: 2018 VS 2024 VS 2034
6.4.2 North America Glucosylceramidase Revenue by Country (2018-2034)
6.4.3 North America Glucosylceramidase Sales Quantity by Country (2018-2034)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Glucosylceramidase Sales by Company
7.1.1 Europe Glucosylceramidase Sales Quantity by Company (2018-2023)
7.1.2 Europe Glucosylceramidase Revenue by Company (2018-2023)
7.2 Europe Glucosylceramidase Market Size by Type
7.2.1 Europe Glucosylceramidase Sales Quantity by Type (2018-2034)
7.2.2 Europe Glucosylceramidase Revenue by Type (2018-2034)
7.3 Europe Glucosylceramidase Market Size by Application
7.3.1 Europe Glucosylceramidase Sales Quantity by Application (2018-2034)
7.3.2 Europe Glucosylceramidase Revenue by Application (2018-2034)
7.4 Europe Glucosylceramidase Market Size by Country
7.4.1 Europe Glucosylceramidase Revenue by Country: 2018 VS 2024 VS 2034
7.4.2 Europe Glucosylceramidase Revenue by Country (2018-2034)
7.4.3 Europe Glucosylceramidase Sales Quantity by Country (2018-2034)
7.4.4 Germany
7.4.5 France
7.4.6 U.K.
7.4.7 Italy
7.4.8 Russia
8 China
8.1 China Glucosylceramidase Sales by Company
8.1.1 China Glucosylceramidase Sales Quantity by Company (2018-2023)
8.1.2 China Glucosylceramidase Revenue by Company (2018-2023)
8.2 China Glucosylceramidase Market Size by Type
8.2.1 China Glucosylceramidase Sales Quantity by Type (2018-2034)
8.2.2 China Glucosylceramidase Revenue by Type (2018-2034)
8.3 China Glucosylceramidase Market Size by Application
8.3.1 China Glucosylceramidase Sales Quantity by Application (2018-2034)
8.3.2 China Glucosylceramidase Revenue by Application (2018-2034)
9 APAC (excluding China)
9.1 APAC Glucosylceramidase Sales by Company
9.1.1 APAC Glucosylceramidase Sales Quantity by Company (2018-2023)
9.1.2 APAC Glucosylceramidase Revenue by Company (2018-2023)
9.2 APAC Glucosylceramidase Market Size by Type
9.2.1 APAC Glucosylceramidase Sales Quantity by Type (2018-2034)
9.2.2 APAC Glucosylceramidase Revenue by Type (2018-2034)
9.3 APAC Glucosylceramidase Market Size by Application
9.3.1 APAC Glucosylceramidase Sales Quantity by Application (2018-2034)
9.3.2 APAC Glucosylceramidase Revenue by Application (2018-2034)
9.4 APAC Glucosylceramidase Market Size by Region
9.4.1 APAC Glucosylceramidase Revenue by Region: 2018 VS 2024 VS 2034
9.4.2 APAC Glucosylceramidase Revenue by Region (2018-2034)
9.4.3 APAC Glucosylceramidase Sales Quantity by Region (2018-2034)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Glucosylceramidase Sales by Company
10.1.1 Middle East, Africa and Latin America Glucosylceramidase Sales Quantity by Company (2018-2023)
10.1.2 Middle East, Africa and Latin America Glucosylceramidase Revenue by Company (2018-2023)
10.2 Middle East, Africa and Latin America Glucosylceramidase Market Size by Type
10.2.1 Middle East, Africa and Latin America Glucosylceramidase Sales Quantity by Type (2018-2034)
10.2.2 Middle East, Africa and Latin America Glucosylceramidase Revenue by Type (2018-2034)
10.3 Middle East, Africa and Latin America Glucosylceramidase Market Size by Application
10.3.1 Middle East, Africa and Latin America Glucosylceramidase Sales Quantity by Application (2018-2034)
10.3.2 Middle East, Africa and Latin America Glucosylceramidase Revenue by Application (2018-2034)
10.4 Middle East, Africa and Latin America Glucosylceramidase Market Size by Country
10.4.1 Middle East, Africa and Latin America Glucosylceramidase Revenue by Country: 2018 VS 2024 VS 2034
10.4.2 Middle East, Africa and Latin America Glucosylceramidase Revenue by Country (2018-2034)
10.4.3 Middle East, Africa and Latin America Glucosylceramidase Sales Quantity by Country (2018-2034)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Israel
10.4.8 GCC Countries
11 Company Profiles
11.1 Amicus Therapeutics, Inc.
11.1.1 Amicus Therapeutics, Inc. Company Information
11.1.2 Amicus Therapeutics, Inc. Overview
11.1.3 Amicus Therapeutics, Inc. Glucosylceramidase Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.1.4 Amicus Therapeutics, Inc. Glucosylceramidase Products and Services
11.1.5 Amicus Therapeutics, Inc. Glucosylceramidase SWOT Analysis
11.1.6 Amicus Therapeutics, Inc. Recent Developments
11.2 Bioorganic Research and Services S.A.
11.2.1 Bioorganic Research and Services S.A. Company Information
11.2.2 Bioorganic Research and Services S.A. Overview
11.2.3 Bioorganic Research and Services S.A. Glucosylceramidase Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.2.4 Bioorganic Research and Services S.A. Glucosylceramidase Products and Services
11.2.5 Bioorganic Research and Services S.A. Glucosylceramidase SWOT Analysis
11.2.6 Bioorganic Research and Services S.A. Recent Developments
11.3 greenovation Biotech GmbH
11.3.1 greenovation Biotech GmbH Company Information
11.3.2 greenovation Biotech GmbH Overview
11.3.3 greenovation Biotech GmbH Glucosylceramidase Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.3.4 greenovation Biotech GmbH Glucosylceramidase Products and Services
11.3.5 greenovation Biotech GmbH Glucosylceramidase SWOT Analysis
11.3.6 greenovation Biotech GmbH Recent Developments
11.4 JCR Pharmaceuticals Co., Ltd.
11.4.1 JCR Pharmaceuticals Co., Ltd. Company Information
11.4.2 JCR Pharmaceuticals Co., Ltd. Overview
11.4.3 JCR Pharmaceuticals Co., Ltd. Glucosylceramidase Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.4.4 JCR Pharmaceuticals Co., Ltd. Glucosylceramidase Products and Services
11.4.5 JCR Pharmaceuticals Co., Ltd. Glucosylceramidase SWOT Analysis
11.4.6 JCR Pharmaceuticals Co., Ltd. Recent Developments
11.5 Pharming Group N.V.
11.5.1 Pharming Group N.V. Company Information
11.5.2 Pharming Group N.V. Overview
11.5.3 Pharming Group N.V. Glucosylceramidase Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.5.4 Pharming Group N.V. Glucosylceramidase Products and Services
11.5.5 Pharming Group N.V. Glucosylceramidase SWOT Analysis
11.5.6 Pharming Group N.V. Recent Developments
11.6 Protalix BioTherapeutics, Inc.
11.6.1 Protalix BioTherapeutics, Inc. Company Information
11.6.2 Protalix BioTherapeutics, Inc. Overview
11.6.3 Protalix BioTherapeutics, Inc. Glucosylceramidase Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.6.4 Protalix BioTherapeutics, Inc. Glucosylceramidase Products and Services
11.6.5 Protalix BioTherapeutics, Inc. Glucosylceramidase SWOT Analysis
11.6.6 Protalix BioTherapeutics, Inc. Recent Developments
11.7 Takeda
11.7.1 Takeda Company Information
11.7.2 Takeda Overview
11.7.3 Takeda Glucosylceramidase Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.7.4 Takeda Glucosylceramidase Products and Services
11.7.5 Takeda Glucosylceramidase SWOT Analysis
11.7.6 Takeda Recent Developments
11.8 The International Biotechnology Center (IBC) Generium
11.8.1 The International Biotechnology Center (IBC) Generium Company Information
11.8.2 The International Biotechnology Center (IBC) Generium Overview
11.8.3 The International Biotechnology Center (IBC) Generium Glucosylceramidase Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.8.4 The International Biotechnology Center (IBC) Generium Glucosylceramidase Products and Services
11.8.5 The International Biotechnology Center (IBC) Generium Glucosylceramidase SWOT Analysis
11.8.6 The International Biotechnology Center (IBC) Generium Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Glucosylceramidase Value Chain Analysis
12.2 Glucosylceramidase Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Glucosylceramidase Production Mode & Process
12.4 Glucosylceramidase Sales and Marketing
12.4.1 Glucosylceramidase Sales Channels
12.4.2 Glucosylceramidase Distributors
12.5 Glucosylceramidase Customers
13 Market Dynamics
13.1 Glucosylceramidase Industry Trends
13.2 Glucosylceramidase Market Drivers
13.3 Glucosylceramidase Market Challenges
13.4 Glucosylceramidase Market Restraints
14 Key Findings
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Glucosylceramidase Market Size Growth Rate (CAGR) by Type, 2018 VS 2024 VS 2034 (US$ Million)
Table 2. Major Manufacturers of AVRRD-02
Table 3. Major Manufacturers of LTI-291
Table 4. Major Manufacturers of NCGC-607
Table 5. Major Manufacturers of Pcgin
Table 6. Major Manufacturers of Others
Table 7. Global Glucosylceramidase Market Size Growth Rate (CAGR) by Application, 2018 VS 2024 VS 2034 (US$ Million)
Table 8. Global Glucosylceramidase Revenue by Region: 2018 VS 2024 VS 2034 (US$ Million)
Table 9. Global Glucosylceramidase Revenue by Region (2018-2023) & (US$ Million)
Table 10. Global Glucosylceramidase Revenue Market Share by Region (2018-2023)
Table 11. Global Glucosylceramidase Revenue by Region (2024-2034) & (US$ Million)
Table 12. Global Glucosylceramidase Revenue Market Share by Region (2024-2034)
Table 13. Global Glucosylceramidase Sales Quantity by Region: 2018 VS 2024 VS 2034 (K Pcs)
Table 14. Global Glucosylceramidase Sales by Region (2018-2023) & (K Pcs)
Table 15. Global Glucosylceramidase Sales Market Share by Region (2018-2023)
Table 16. Global Glucosylceramidase Sales by Region (2024-2034) & (K Pcs)
Table 17. Global Glucosylceramidase Sales Market Share by Region (2024-2034)
Table 18. Global Glucosylceramidase Sales Quantity by Manufacturers (2018-2023) & (K Pcs)
Table 19. Global Glucosylceramidase Sales Quantity Share by Manufacturers (2018-2023)
Table 20. Global Glucosylceramidase Revenue by Manufacturers (2018-2023) & (US$ Million)
Table 21. Global Glucosylceramidase Revenue Share by Manufacturers (2018-2023)
Table 22. Global Glucosylceramidase Price by Manufacturers 2018-2023 (USD/Pcs)
Table 23. Global Key Players of Glucosylceramidase, Industry Ranking, 2021 VS 2024
Table 24. Global Glucosylceramidase Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 25. Global Glucosylceramidase by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Glucosylceramidase as of 2024)
Table 26. Global Key Manufacturers of Glucosylceramidase, Manufacturing Base Distribution and Headquarters
Table 27. Global Key Manufacturers of Glucosylceramidase, Product Offered and Application
Table 28. Global Key Manufacturers of Glucosylceramidase, Date of Enter into This Industry
Table 29. Mergers & Acquisitions, Expansion Plans
Table 30. Global Glucosylceramidase Sales Quantity by Type (2018-2023) & (K Pcs)
Table 31. Global Glucosylceramidase Sales Quantity by Type (2024-2034) & (K Pcs)
Table 32. Global Glucosylceramidase Sales Quantity Share by Type (2018-2023)
Table 33. Global Glucosylceramidase Sales Quantity Share by Type (2024-2034)
Table 34. Global Glucosylceramidase Revenue by Type (2018-2023) & (US$ Million)
Table 35. Global Glucosylceramidase Revenue by Type (2024-2034) & (US$ Million)
Table 36. Global Glucosylceramidase Revenue Share by Type (2018-2023)
Table 37. Global Glucosylceramidase Revenue Share by Type (2024-2034)
Table 38. Glucosylceramidase Price by Type (2018-2023) & (USD/Pcs)
Table 39. Global Glucosylceramidase Price Forecast by Type (2024-2034) & (USD/Pcs)
Table 40. Global Glucosylceramidase Sales Quantity by Application (2018-2023) & (K Pcs)
Table 41. Global Glucosylceramidase Sales Quantity by Application (2024-2034) & (K Pcs)
Table 42. Global Glucosylceramidase Sales Quantity Share by Application (2018-2023)
Table 43. Global Glucosylceramidase Sales Quantity Share by Application (2024-2034)
Table 44. Global Glucosylceramidase Revenue by Application (2018-2023) & (US$ Million)
Table 45. Global Glucosylceramidase Revenue by Application (2024-2034) & (US$ Million)
Table 46. Global Glucosylceramidase Revenue Share by Application (2018-2023)
Table 47. Global Glucosylceramidase Revenue Share by Application (2024-2034)
Table 48. Glucosylceramidase Price by Application (2018-2023) & (USD/Pcs)
Table 49. Global Glucosylceramidase Price Forecast by Application (2024-2034) & (USD/Pcs)
Table 50. North America Glucosylceramidase Revenue by Company (2018-2023) & (US$ Million)
Table 51. North America Glucosylceramidase Sales Quantity by Company (2018-2023) & (K Pcs)
Table 52. North America Glucosylceramidase Sales Quantity by Type (2018-2023) & (K Pcs)
Table 53. North America Glucosylceramidase Sales Quantity by Type (2024-2034) & (K Pcs)
Table 54. North America Glucosylceramidase Revenue by Type (2018-2023) & (US$ Million)
Table 55. North America Glucosylceramidase Revenue by Type (2024-2034) & (US$ Million)
Table 56. North America Glucosylceramidase Sales Quantity by Application (2018-2023) & (K Pcs)
Table 57. North America Glucosylceramidase Sales Quantity by Application (2024-2034) & (K Pcs)
Table 58. North America Glucosylceramidase Revenue by Application (2018-2023) & (US$ Million)
Table 59. North America Glucosylceramidase Revenue by Application (2024-2034) & (US$ Million)
Table 60. North America Glucosylceramidase Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 61. North America Glucosylceramidase Revenue by Country (2018-2023) & (US$ Million)
Table 62. North America Glucosylceramidase Revenue by Country (2024-2034) & (US$ Million)
Table 63. North America Glucosylceramidase Sales Quantity by Country (2018-2023) & (K Pcs)
Table 64. North America Glucosylceramidase Sales Quantity by Country (2024-2034) & (K Pcs)
Table 65. Europe Glucosylceramidase Sales Quantity by Company (2018-2023) & (K Pcs)
Table 66. Europe Glucosylceramidase Revenue by Company (2018-2023) & (US$ Million)
Table 67. Europe Glucosylceramidase Sales Quantity by Type (2018-2023) & (K Pcs)
Table 68. Europe Glucosylceramidase Sales Quantity by Type (2024-2034) & (K Pcs)
Table 69. Europe Glucosylceramidase Revenue by Type (2018-2023) & (US$ Million)
Table 70. Europe Glucosylceramidase Revenue by Type (2024-2034) & (US$ Million)
Table 71. Europe Glucosylceramidase Sales Quantity by Application (2018-2023) & (K Pcs)
Table 72. Europe Glucosylceramidase Sales Quantity by Application (2024-2034) & (K Pcs)
Table 73. Europe Glucosylceramidase Revenue by Application (2018-2023) & (US$ Million)
Table 74. Europe Glucosylceramidase Revenue by Application (2024-2034) & (US$ Million)
Table 75. Europe Glucosylceramidase Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 76. Europe Glucosylceramidase Revenue by Country (2018-2023) & (US$ Million)
Table 77. Europe Glucosylceramidase Revenue by Country (2024-2034) & (US$ Million)
Table 78. Europe Glucosylceramidase Sales Quantity by Country (2018-2023) & (K Pcs)
Table 79. Europe Glucosylceramidase Sales Quantity by Country (2024-2034) & (K Pcs)
Table 80. China Glucosylceramidase Sales Quantity by Company (2018-2023) & (K Pcs)
Table 81. China Glucosylceramidase Revenue by Company (2018-2023) & (US$ Million)
Table 82. China Glucosylceramidase Sales Quantity by Type (2018-2023) & (K Pcs)
Table 83. China Glucosylceramidase Sales Quantity by Type (2024-2034) & (K Pcs)
Table 84. China Glucosylceramidase Revenue by Type (2018-2023) & (US$ Million)
Table 85. China Glucosylceramidase Revenue by Type (2024-2034) & (US$ Million)
Table 86. China Glucosylceramidase Sales Quantity by Application (2018-2023) & (K Pcs)
Table 87. China Glucosylceramidase Sales Quantity by Application (2024-2034) & (K Pcs)
Table 88. China Glucosylceramidase Revenue by Application (2018-2023) & (US$ Million)
Table 89. China Glucosylceramidase Revenue by Application (2024-2034) & (US$ Million)
Table 90. APAC Glucosylceramidase Sales Quantity by Company (2018-2023) & (K Pcs)
Table 91. APAC Glucosylceramidase Revenue by Company (2018-2023) & (US$ Million)
Table 92. APAC Glucosylceramidase Sales Quantity by Type (2018-2023) & (K Pcs)
Table 93. APAC Glucosylceramidase Sales Quantity by Type (2024-2034) & (K Pcs)
Table 94. APAC Glucosylceramidase Revenue by Type (2018-2023) & (US$ Million)
Table 95. APAC Glucosylceramidase Revenue by Type (2024-2034) & (US$ Million)
Table 96. APAC Glucosylceramidase Sales Quantity by Application (2018-2023) & (K Pcs)
Table 97. APAC Glucosylceramidase Sales Quantity by Application (2024-2034) & (K Pcs)
Table 98. APAC Glucosylceramidase Revenue by Application (2018-2023) & (US$ Million)
Table 99. APAC Glucosylceramidase Revenue by Application (2024-2034) & (US$ Million)
Table 100. APAC Glucosylceramidase Revenue by Region: 2018 VS 2024 VS 2034 (US$ Million)
Table 101. APAC Glucosylceramidase Revenue by Region (2018-2023) & (US$ Million)
Table 102. APAC Glucosylceramidase Revenue by Region (2024-2034) & (US$ Million)
Table 103. APAC Glucosylceramidase Sales Quantity by Region (2018-2023) & (K Pcs)
Table 104. APAC Glucosylceramidase Sales Quantity by Region (2024-2034) & (K Pcs)
Table 105. Middle East, Africa and Latin America Glucosylceramidase Sales Quantity by Company (2018-2023) & (K Pcs)
Table 106. Middle East, Africa and Latin America Glucosylceramidase Revenue by Company (2018-2023) & (US$ Million)
Table 107. Middle East, Africa and Latin America Glucosylceramidase Sales Quantity by Type (2018-2023) & (K Pcs)
Table 108. Middle East, Africa and Latin America Glucosylceramidase Sales Quantity by Type (2024-2034) & (K Pcs)
Table 109. Middle East, Africa and Latin America Glucosylceramidase Revenue by Type (2018-2023) & (US$ Million)
Table 110. Middle East, Africa and Latin America Glucosylceramidase Revenue by Type (2024-2034) & (US$ Million)
Table 111. Middle East, Africa and Latin America Glucosylceramidase Sales Quantity by Application (2018-2023) & (K Pcs)
Table 112. Middle East, Africa and Latin America Glucosylceramidase Sales Quantity by Application (2024-2034) & (K Pcs)
Table 113. Middle East, Africa and Latin America Glucosylceramidase Revenue by Application (2018-2023) & (US$ Million)
Table 114. Middle East, Africa and Latin America Glucosylceramidase Revenue by Application (2024-2034) & (US$ Million)
Table 115. Middle East, Africa and Latin America Glucosylceramidase Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 116. Middle East, Africa and Latin America Glucosylceramidase Revenue by Country (2018-2023) & (US$ Million)
Table 117. Middle East, Africa and Latin America Glucosylceramidase Revenue by Country (2024-2034) & (US$ Million)
Table 118. Middle East, Africa and Latin America Glucosylceramidase Sales Quantity by Country (2018-2023) & (K Pcs)
Table 119. Middle East, Africa and Latin America Glucosylceramidase Sales Quantity by Country (2024-2034) & (K Pcs)
Table 120. Amicus Therapeutics, Inc. Company Information
Table 121. Amicus Therapeutics, Inc. Description and Overview
Table 122. Amicus Therapeutics, Inc. Glucosylceramidase Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2023)
Table 123. Amicus Therapeutics, Inc. Glucosylceramidase Product and Services
Table 124. Amicus Therapeutics, Inc. Glucosylceramidase SWOT Analysis
Table 125. Amicus Therapeutics, Inc. Recent Developments
Table 126. Bioorganic Research and Services S.A. Company Information
Table 127. Bioorganic Research and Services S.A. Description and Overview
Table 128. Bioorganic Research and Services S.A. Glucosylceramidase Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2023)
Table 129. Bioorganic Research and Services S.A. Glucosylceramidase Product and Services
Table 130. Bioorganic Research and Services S.A. Glucosylceramidase SWOT Analysis
Table 131. Bioorganic Research and Services S.A. Recent Developments
Table 132. greenovation Biotech GmbH Company Information
Table 133. greenovation Biotech GmbH Description and Overview
Table 134. greenovation Biotech GmbH Glucosylceramidase Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2023)
Table 135. greenovation Biotech GmbH Glucosylceramidase Product and Services
Table 136. greenovation Biotech GmbH Glucosylceramidase SWOT Analysis
Table 137. greenovation Biotech GmbH Recent Developments
Table 138. JCR Pharmaceuticals Co., Ltd. Company Information
Table 139. JCR Pharmaceuticals Co., Ltd. Description and Overview
Table 140. JCR Pharmaceuticals Co., Ltd. Glucosylceramidase Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2023)
Table 141. JCR Pharmaceuticals Co., Ltd. Glucosylceramidase Product and Services
Table 142. JCR Pharmaceuticals Co., Ltd. Glucosylceramidase SWOT Analysis
Table 143. JCR Pharmaceuticals Co., Ltd. Recent Developments
Table 144. Pharming Group N.V. Company Information
Table 145. Pharming Group N.V. Description and Overview
Table 146. Pharming Group N.V. Glucosylceramidase Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2023)
Table 147. Pharming Group N.V. Glucosylceramidase Product and Services
Table 148. Pharming Group N.V. Glucosylceramidase SWOT Analysis
Table 149. Pharming Group N.V. Recent Developments
Table 150. Protalix BioTherapeutics, Inc. Company Information
Table 151. Protalix BioTherapeutics, Inc. Description and Overview
Table 152. Protalix BioTherapeutics, Inc. Glucosylceramidase Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2023)
Table 153. Protalix BioTherapeutics, Inc. Glucosylceramidase Product and Services
Table 154. Protalix BioTherapeutics, Inc. Glucosylceramidase SWOT Analysis
Table 155. Protalix BioTherapeutics, Inc. Recent Developments
Table 156. Takeda Company Information
Table 157. Takeda Description and Overview
Table 158. Takeda Glucosylceramidase Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2023)
Table 159. Takeda Glucosylceramidase Product and Services
Table 160. Takeda Glucosylceramidase SWOT Analysis
Table 161. Takeda Recent Developments
Table 162. The International Biotechnology Center (IBC) Generium Company Information
Table 163. The International Biotechnology Center (IBC) Generium Description and Overview
Table 164. The International Biotechnology Center (IBC) Generium Glucosylceramidase Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2023)
Table 165. The International Biotechnology Center (IBC) Generium Glucosylceramidase Product and Services
Table 166. The International Biotechnology Center (IBC) Generium Glucosylceramidase SWOT Analysis
Table 167. The International Biotechnology Center (IBC) Generium Recent Developments
Table 168. Key Raw Materials Lists
Table 169. Raw Materials Key Suppliers Lists
Table 170. Glucosylceramidase Distributors List
Table 171. Glucosylceramidase Customers List
Table 172. Glucosylceramidase Market Trends
Table 173. Glucosylceramidase Market Drivers
Table 174. Glucosylceramidase Market Challenges
Table 175. Glucosylceramidase Market Restraints
Table 176. Research Programs/Design for This Report
Table 177. Key Data Information from Secondary Sources
Table 178. Key Data Information from Primary Sources
List of Figures
Figure 1. Glucosylceramidase Product Picture
Figure 2. Global Glucosylceramidase Market Size Growth Rate by Type, 2018 VS 2024 VS 2034 (US$ Million)
Figure 3. Global Glucosylceramidase Market Share by Type in 2024 & 2034
Figure 4. AVRRD-02 Product Picture
Figure 5. LTI-291 Product Picture
Figure 6. NCGC-607 Product Picture
Figure 7. Pcgin Product Picture
Figure 8. Others Product Picture
Figure 9. Global Glucosylceramidase Market Size Growth Rate by Application, 2018 VS 2024 VS 2034 (US$ Million)
Figure 10. Global Glucosylceramidase Market Share by Application in 2024 & 2034
Figure 11. Genetic Disorders
Figure 12. Gaucher Disease
Figure 13. Parkinson's Disease
Figure 14. Others
Figure 15. Glucosylceramidase Report Years Considered
Figure 16. Global Glucosylceramidase Revenue, (US$ Million), 2018 VS 2024 VS 2034
Figure 17. Global Glucosylceramidase Revenue 2018-2034 (US$ Million)
Figure 18. Global Glucosylceramidase Revenue Market Share by Region in Percentage: 2024 Versus 2034
Figure 19. Global Glucosylceramidase Sales Quantity 2018-2034 (K Pcs)
Figure 20. Global Glucosylceramidase Sales Quantity Market Share by Region (2018-2023)
Figure 21. Global Glucosylceramidase Sales Quantity Market Share by Region (2024-2034)
Figure 22. North America Glucosylceramidase Sales Quantity YoY (2018-2034) & (K Pcs)
Figure 23. North America Glucosylceramidase Revenue YoY (2018-2034) & (US$ Million)
Figure 24. Europe Glucosylceramidase Sales Quantity YoY (2018-2034) & (K Pcs)
Figure 25. Europe Glucosylceramidase Revenue YoY (2018-2034) & (US$ Million)
Figure 26. China Glucosylceramidase Sales Quantity YoY (2018-2034) & (K Pcs)
Figure 27. China Glucosylceramidase Revenue YoY (2018-2034) & (US$ Million)
Figure 28. APAC Glucosylceramidase Sales Quantity YoY (2018-2034) & (K Pcs)
Figure 29. APAC Glucosylceramidase Revenue YoY (2018-2034) & (US$ Million)
Figure 30. Middle East, Africa and Latin America Glucosylceramidase Sales Quantity YoY (2018-2034) & (K Pcs)
Figure 31. Middle East, Africa and Latin America Glucosylceramidase Revenue YoY (2018-2034) & (US$ Million)
Figure 32. The Top 10 and Top 5 Players Market Share by Glucosylceramidase Sales Quantity in 2024
Figure 33. The Top 10 and Top 5 Players Market Share by Glucosylceramidase Revenue in 2024
Figure 34. Glucosylceramidase Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2024
Figure 35. Global Glucosylceramidase Sales Quantity Market Share by Type (2018-2034)
Figure 36. Global Glucosylceramidase Revenue Market Share by Type (2018-2034)
Figure 37. Global Glucosylceramidase Sales Quantity Market Share by Application (2018-2034)
Figure 38. Global Glucosylceramidase Revenue Market Share by Application (2018-2034)
Figure 39. North America Glucosylceramidase Revenue Market Share by Company in 2024
Figure 40. North America Glucosylceramidase Sales Quantity Market Share by Company in 2024
Figure 41. North America Glucosylceramidase Sales Quantity Market Share by Type (2018-2034)
Figure 42. North America Glucosylceramidase Revenue Market Share by Type (2018-2034)
Figure 43. North America Glucosylceramidase Sales Quantity Market Share by Application (2018-2034)
Figure 44. North America Glucosylceramidase Revenue Market Share by Application (2018-2034)
Figure 45. North America Glucosylceramidase Revenue Share by Country (2018-2034)
Figure 46. North America Glucosylceramidase Sales Quantity Share by Country (2018-2034)
Figure 47. U.S. Glucosylceramidase Revenue (2018-2034) & (US$ Million)
Figure 48. Canada Glucosylceramidase Revenue (2018-2034) & (US$ Million)
Figure 49. Europe Glucosylceramidase Sales Quantity Market Share by Company in 2024
Figure 50. Europe Glucosylceramidase Revenue Market Share by Company in 2024
Figure 51. Europe Glucosylceramidase Sales Quantity Market Share by Type (2018-2034)
Figure 52. Europe Glucosylceramidase Revenue Market Share by Type (2018-2034)
Figure 53. Europe Glucosylceramidase Sales Quantity Market Share by Application (2018-2034)
Figure 54. Europe Glucosylceramidase Revenue Market Share by Application (2018-2034)
Figure 55. Europe Glucosylceramidase Revenue Share by Country (2018-2034)
Figure 56. Europe Glucosylceramidase Sales Quantity Share by Country (2018-2034)
Figure 57. Germany Glucosylceramidase Revenue (2018-2034) & (US$ Million)
Figure 58. France Glucosylceramidase Revenue (2018-2034) & (US$ Million)
Figure 59. U.K. Glucosylceramidase Revenue (2018-2034) & (US$ Million)
Figure 60. Italy Glucosylceramidase Revenue (2018-2034) & (US$ Million)
Figure 61. Russia Glucosylceramidase Revenue (2018-2034) & (US$ Million)
Figure 62. China Glucosylceramidase Sales Quantity Market Share by Company in 2024
Figure 63. China Glucosylceramidase Revenue Market Share by Company in 2024
Figure 64. China Glucosylceramidase Sales Quantity Market Share by Type (2018-2034)
Figure 65. China Glucosylceramidase Revenue Market Share by Type (2018-2034)
Figure 66. China Glucosylceramidase Sales Quantity Market Share by Application (2018-2034)
Figure 67. China Glucosylceramidase Revenue Market Share by Application (2018-2034)
Figure 68. APAC Glucosylceramidase Sales Quantity Market Share by Company in 2024
Figure 69. APAC Glucosylceramidase Revenue Market Share by Company in 2024
Figure 70. APAC Glucosylceramidase Sales Quantity Market Share by Type (2018-2034)
Figure 71. APAC Glucosylceramidase Revenue Market Share by Type (2018-2034)
Figure 72. APAC Glucosylceramidase Sales Quantity Market Share by Application (2018-2034)
Figure 73. APAC Glucosylceramidase Revenue Market Share by Application (2018-2034)
Figure 74. APAC Glucosylceramidase Revenue Share by Region (2018-2034)
Figure 75. APAC Glucosylceramidase Sales Quantity Share by Region (2018-2034)
Figure 76. Japan Glucosylceramidase Revenue (2018-2034) & (US$ Million)
Figure 77. South Korea Glucosylceramidase Revenue (2018-2034) & (US$ Million)
Figure 78. China Taiwan Glucosylceramidase Revenue (2018-2034) & (US$ Million)
Figure 79. Southeast Asia Glucosylceramidase Revenue (2018-2034) & (US$ Million)
Figure 80. India Glucosylceramidase Revenue (2018-2034) & (US$ Million)
Figure 81. Middle East, Africa and Latin America Glucosylceramidase Sales Quantity Market Share by Company in 2024
Figure 82. Middle East, Africa and Latin America Glucosylceramidase Revenue Market Share by Company in 2024
Figure 83. Middle East, Africa and Latin America Glucosylceramidase Sales Quantity Market Share by Type (2018-2034)
Figure 84. Middle East, Africa and Latin America Glucosylceramidase Revenue Market Share by Type (2018-2034)
Figure 85. Middle East, Africa and Latin America Glucosylceramidase Sales Quantity Market Share by Application (2018-2034)
Figure 86. Middle East, Africa and Latin America Glucosylceramidase Revenue Market Share by Application (2018-2034)
Figure 87. Middle East, Africa and Latin America Glucosylceramidase Sales Quantity Share by Country (2018-2034)
Figure 88. Middle East, Africa and Latin America Glucosylceramidase Revenue Share by Country (2018-2034)
Figure 89. Brazil Glucosylceramidase Revenue (2018-2034) & (US$ Million)
Figure 90. Mexico Glucosylceramidase Revenue (2018-2034) & (US$ Million)
Figure 91. Turkey Glucosylceramidase Revenue (2018-2034) & (US$ Million)
Figure 92. Israel Glucosylceramidase Revenue (2018-2034) & (US$ Million)
Figure 93. GCC Countries Glucosylceramidase Revenue (2018-2034) & (US$ Million)
Figure 94. Glucosylceramidase Value Chain
Figure 95. Glucosylceramidase Production Process
Figure 96. Channels of Distribution (Direct Vs Distribution)
Figure 97. Distributors Profiles
Figure 98. Bottom-up and Top-down Approaches for This Report
Figure 99. Data Triangulation
Figure 100. Key Executives Interviewed